GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Days Sales Outstanding

Cantourage Group SE (XTER:HIGH) Days Sales Outstanding : 579.03 (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Days Sales Outstanding?

Cantourage Group SE's average Accounts Receivable for the six months ended in Jun. 2023 was €1.90 Mil. Cantourage Group SE's Revenue for the six months ended in Jun. 2023 was €0.60 Mil. Hence, Cantourage Group SE's Days Sales Outstanding for the six months ended in Jun. 2023 was 579.03.

The historical rank and industry rank for Cantourage Group SE's Days Sales Outstanding or its related term are showing as below:

XTER:HIGH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.64   Med: 67.49   Max: 577.11
Current: 577.11

During the past 4 years, Cantourage Group SE's highest Days Sales Outstanding was 577.11. The lowest was 41.64. And the median was 67.49.

XTER:HIGH's Days Sales Outstanding is ranked worse than
98.5% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.45 vs XTER:HIGH: 577.11

Cantourage Group SE's Days Sales Outstanding increased from Jun. 2022 (0.00) to Jun. 2023 (579.03).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Cantourage Group SE Days Sales Outstanding Historical Data

The historical data trend for Cantourage Group SE's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Days Sales Outstanding Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
- 67.49 41.64 551.74

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Days Sales Outstanding Get a 7-Day Free Trial - - - 221.24 579.03

Competitive Comparison of Cantourage Group SE's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantourage Group SE's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Days Sales Outstanding falls into.


Cantourage Group SE Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cantourage Group SE's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (1.092 + 0.731) / 2 ) / 0.603*365
=0.9115 / 0.603*365
=551.74

Cantourage Group SE's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

Days Sales Outstanding (Q: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (0.731 + 3.07) / 2 ) / 0.599*365 / 2
=1.9005 / 0.599*365 / 2
=579.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE  (XTER:HIGH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cantourage Group SE Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantourage Group SE (XTER:HIGH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Days Sales Outstanding
Comparable Companies
Traded in Other Exchanges
HIGH:Germany
Address
Feurigstrasse 54, Berlin, DEU, 10827
Website
https://www.cantourage.com
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines